IBTimes -
29 Oct 2015 23:32
Shares of Valeant Pharmaceuticals International Inc. (NYSE:VRX) suffered late Thursday on news that health chain CVS had severed ties with a specialty pharmacy whose convoluted relationship with Valeant has stirred shareholder unrest in the past week. The news, reported by Dow Jones, comes as executives try to right the ship after a spate of damaging reports.
Share this Article